Talk:Intraductal carcinoma of the prostate: Difference between revisions
Jump to navigation
Jump to search
→BRCA2: new section |
→IDCP in GG1: new section |
||
| Line 2: | Line 2: | ||
https://pubmed.ncbi.nlm.nih.gov/30808988/ | https://pubmed.ncbi.nlm.nih.gov/30808988/ | ||
== IDCP in GG1 == | |||
https://pmc.ncbi.nlm.nih.gov/articles/PMC10669759/ | |||
".. evidence to date suggests that IDC-P should generally be graded to avoid undergrading and to minimize the overuse of basal cell stains .. The only exception to this rule is when IDC-P is present in association with GG1 PCa or in pure form without concomitant PCa, which is a rare scenario and accounts for ~2% of IDC-P." | |||